Search research articles
Contact Us
Filters
Showing results (521-530 of 941) with videos related to
Page
of 95
Sort By:
Nucleic Acids Research
|
December 23, 2021
Regulation of AR mRNA translation in response to acute AR pathway inhibition
Syam Prakash Somasekharan, Neetu Saxena, Fan Zhang, et al.
World Journal of Urology
|
August 29, 2019
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator
Miles P Mannas, Taeweon Lee, Connor M Forbes, et al.
European Urology
|
August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
International Journal of Cancer
|
February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model
Sifeng Qu, Hui Xue, Xin Dong, et al.
Molecular Cancer Therapeutics
|
July 26, 2019
GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
Vito Cucchiara, Joy C Yang, Chengfei Liu, et al.
The British Journal of Radiology
|
November 1, 1983
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man
N M Bleehen, R M Grant, D H Jones, et al.
JCO Clinical Cancer Informatics
|
June 20, 2024
Prostate Cancer Risk Stratification by Digital Histopathology and Deep Learning
Yanan Shao, Roozbeh Bazargani, Davood Karimi, et al.
Cancer Research
|
December 3, 2004
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model
Sandra L Krueckl, Robert A Sikes, N Magnus Edlund, et al.
Molecular Cancer Research : MCR
|
January 14, 2010
Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells
Amina Zoubeidi, Susan Ettinger, Eliana Beraldi, et al.
The Prostate
|
September 12, 2008
Insulin receptor expression by human prostate cancers
Michael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Page
of 95
Search research articles
Search
Showing results (521-530 of 941) with videos related to
Sort By:
Page
of 95
Nucleic Acids Research
|
December 23, 2021
Regulation of AR mRNA translation in response to acute AR pathway inhibition
Syam Prakash Somasekharan, Neetu Saxena, Fan Zhang, et al.
World Journal of Urology
|
August 29, 2019
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator
Miles P Mannas, Taeweon Lee, Connor M Forbes, et al.
European Urology
|
August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
International Journal of Cancer
|
February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model
Sifeng Qu, Hui Xue, Xin Dong, et al.
Molecular Cancer Therapeutics
|
July 26, 2019
GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
Vito Cucchiara, Joy C Yang, Chengfei Liu, et al.
The British Journal of Radiology
|
November 1, 1983
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man
N M Bleehen, R M Grant, D H Jones, et al.
JCO Clinical Cancer Informatics
|
June 20, 2024
Prostate Cancer Risk Stratification by Digital Histopathology and Deep Learning
Yanan Shao, Roozbeh Bazargani, Davood Karimi, et al.
Cancer Research
|
December 3, 2004
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model
Sandra L Krueckl, Robert A Sikes, N Magnus Edlund, et al.
Molecular Cancer Research : MCR
|
January 14, 2010
Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells
Amina Zoubeidi, Susan Ettinger, Eliana Beraldi, et al.
The Prostate
|
September 12, 2008
Insulin receptor expression by human prostate cancers
Michael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Page
of 95